References
- Lasala GP, Minguell JJ. Bone marrow-derived stem/progenitor cells: Their use in clinical studies for the treatment of myocardial infarction. Heart Lung Circ. 2009;18:171–80.
- Wollert KC, Drexler H. Cell therapy for the treatment of coronary heart disease: A critical appraisal. Nat Rev Cardiol. 2010;7: 204–15.
- Minguell JJ, Erices A. Mesenchymal stem cells and the treatment of cardiac disease. Exp Biol Med. 2006;231:39–49.
- Minguell JJ, Florenzano FM, Ramírez MR, Martínez RF, Lasala GP. Intracoronary infusion of a combination of bone marrow-derived stem cells in dogs. Exp Clin Cardiol. 2010;15:17–20.
- Lasala GP, Silva JA, Barry A, Kusnick BA, Minguell JJ. Combination stem cells therapy for the treatment of medically refractory coronary ischemia: A phase 1 study. Cardiovas Revasc Med. 2011;12:29–34.
- Oron U, Halevy O, Yaakobi T, Hayam G, Gepstein L, Wolf T, . Technical delivery of myogenic cells through an endocardial injection catheter for myocardial cell implantation. Int J Cardiovasc Intervent. 2000;3:227–30.
- Laham RJ, Post M, Rezaee M, Donnell-Fink L, Wykrzykowska JJ, Lee SU, . Transendocardial and transepicardial intramyocardial fibroblast growth factor-2 administration: myocardial and tissue distribution. Drug Metab Dispos. 2005;33:1101–7.
- Smits PC, Nienaber C, Colombo A, Ince H, Carlino M, Theuns DA, . Myocardial repair by percutaneous cell transplantation of autologous skeletal myoblast as a stand alone procedure in post myocardial infarction chronic heart failure patients. EuroIntervention 2006;1:417–24.
- Losordo DW, Schatz RA, White CJ, Udelson JE, Veereshwarayya V, Durgin M, . Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial. Circulation 2007;115:3165–72.
- Minguell JJ, Erices E, Conget P. Mesenchymal stem cells Exp Biol Med. 2001;226:507–520.
- Conget PA, Minguell JJ. Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J Cell Physiol. 1999;181:67–73.
- Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, . Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8:315–7.
- Chan CK, Liao S, Li B, Lareu RR, Larrick JW, Ramakrishna S, . Early adhesive behavior of bone-marrow-derived mesenchymal stem cells on collagen electrospun fibers. Biomed Mater. 2009;4:Epub 2009 May 14.
- Yao J, Radin S, Reilly G, Leboy PS, Ducheyne P. Solution-mediated effect of bioactive glass in poly (lactic-co-glycolic acid)-bioactive glass composites on osteogenesis of marrow stromal cells. J Biomed Mater Res A 2005;75:794–801.
- Freyman T, Polin G, Osman H, Crary J, Lu M, Cheng L, . A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur Heart J. 2006;27:1114–22.
- Perin EC, Silva GV, Assad JA, Vela D, Buja LM, Sousa AL, . Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction. J Mol Cell Cardiol. 2008;44:486–95.